FTC Accuses Martin Shkreli of Violating Lifetime Pharmaceutical Industry Ban
The Federal Trade Commission states that Martin Shkreli violated a lifetime ban prohibiting him from participating in the pharmaceutical industry after he openly discussed trading biotech stocks during a public livestream. This regulatory enforcement highlights ongoing legal oversight of Shkreli, whose previous market manipulation convictions led to the permanent ban from the sector.
Source: Ars Technica